A genotype directed dose-finding study of irinotecan (CPT-11) by groups of uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2006
At a glance
- Drugs Irinotecan (Primary)
- Indications Colorectal cancer; Gastric cancer
- Focus Adverse reactions; Pharmacogenomic
- 07 Nov 2006 New trial record.